COURSE FULLY BOOKED – please contact us for future courses or purchase the recording available from Friday

Key considerations from a BD, legal and financial perspective

That crucial stage, clarity after negotiation. Learn from contemporary dealmakers on how to structure your agreement in principle for the foundation of a binding agreement.

This afternoon virtual workshop will consider drafting a term sheet from both the Business Development (session 1) and Legal perspectives (session 2), together providing a comprehensive primer. The subject will be explored further using a term sheet case study.

Presented By

• Kay Tait, Senior Transaction Director, Business Development Operations, AstraZeneca
• Umaima Ahmad, Associate Transaction Director, Business Development Operations, AstraZeneca
• Jarlath Astin, Senior Legal Counsel, AstraZeneca
• Dan Briody, Deal Finance Director, AstraZeneca

Learning Outcomes

• Understand the pros and cons of using a term sheet
• Understand the parts of a term sheet that are typically binding or non-binding
• Understand how deal structure and stage influences term sheet content
• Understand the typical content of a term sheet
• Understand financing structures typically seen across life science BD deals
• Apply your understanding through reviewing a term sheet for an in-licensing transaction
• Be able to construct and prioritise an issues list